Company Filing History:
1 out of 1 
1 out of 5,089 
1 out of 1,744 
Years Active: 2025
Title: The Innovations of Julien Jean-Marius Soule
Introduction
Julien Jean-Marius Soule is a notable inventor based in Montpellier, France. He has made significant contributions to the field of biotechnology, particularly in the development of single-domain antibodies. His work has implications for various applications in medical research and therapeutic development.
Latest Patents
Soule holds a patent for a single-domain antibody that binds to the G protein alpha. This invention comprises an amino acid sequence consisting of three CDR regions (CDR1 to CDR3) and four hinge regions (FR1 to FR4). The formula for this antibody is represented as FR1-CDR1-FR2-CDR2-FR3-CDR3-FR4. Notably, it has a dissociation constant (Kd), measured in FRET, of less than 100 nM. This innovation showcases his expertise in antibody engineering and its potential applications in therapeutic settings.
Career Highlights
Throughout his career, Julien Jean-Marius Soule has worked with prominent organizations such as Ciscio Bioassays and the Centre National de la Recherche Scientifique. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Some of his notable coworkers include Thomas Fabien Michel Roux and Elodie Julie Dupuis. Their collaborative efforts have further advanced the research and development of innovative biotechnological solutions.
Conclusion
Julien Jean-Marius Soule's contributions to the field of biotechnology, particularly through his patent on single-domain antibodies, highlight his role as an influential inventor. His work continues to inspire advancements in medical research and therapeutic applications.